Skip to content
Psychedelic therapies are greatly enhanced with preparation, guidance, and integration, particularly in healthcare use cases. Unfortunately, this is often limited by logistics such as cost and labor for in-person treatments. As we increase access to psychedelic therapies in the upcoming future, we need to focus on safety and outcomes so that traditional healthcare stakeholders will more readily accept these novel interventions.

Details

  • Second Stage
Date:
11/04/2022
Start Time:
2:40 pm
End Time:
15:25

Dr. Sandeep Prakash, Ph.D.

Co-Founder & Chief Scientific Officer of Entheo Digital

Sandeep Prakash is a psychologist and researcher specializing in psychedelic medicine and virtual reality. Sandeep earned his Master’s and Doctoral degrees from the California Institute of Integral St…

Chad Olin

CEO & Co-Founder, Supermind

Chad Olin is the CEO and Co-Founder of Supermind, a company democratizing access to brainwave technology with a biosensing EEG hat. Supermind provides quantified self-mastery through 20 minute “super”…

Dr. Hillary Lin, MD

Co-founder and CEO, Curio

Hillary Lin, MD is a Stanford-trained physician and Co-founder and CEO of Curio, a psychedelics healthcare company an AI-assisted safety and outcomes focus. Her research and clinical work has been foc…

Evan Buckman

COO, Collab.Health

Evan is a mycologist, biotechnologist and serial entrepreneur who is passionate about the intersection between technology and holistic wellness. His personal health journey inspired him to delve into …

Get Recordings Now!

Easily access the recordings for your favorite Wonderland sessions, allowing you to revisit the discussions and insights shared by our visionary speakers.

Buy Now